Interdicting Gq activation in airway disease by receptor-dependent and receptor-independent mechanisms

Molecular Pharmacology

Volumn 89, Issue 1, 2016, Pages 94-104

  Carr, Richard ^a   Koziol White, Cynthia ^b   Zhang, Jie ^c   Lam, Hong ^b   An, Steven S ^b   Tall, Gregory G ^c   Panettieri, Reynold A ^d   Benovic, Jeffrey L ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CYCLODEPSIPEPTIDE; FR 900359; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); HISTAMINE H1 RECEPTOR; MUSCARINIC ACETYLCHOLINE M3; MUSCARINIC RECEPTOR; P4PAL 10; PROTEIN INHIBITOR; PROTEIN KINASE B; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 4; UNCLASSIFIED DRUG; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; OLIGOPEPTIDE; PALMITOYL-SERYL-GLYCYL-ARGINYL-ARGINYL-TYROSYL-GLYCYL-HISTIDYL-ALANYL-LEUCYL-ARGININE;

ARTICLE; BRONCHOCONSTRICTION; CALCIUM MOBILIZATION; CELL GROWTH; CONTROLLED STUDY; EMBRYO; ENZYME PHOSPHORYLATION; EX VIVO STUDY; FEMALE; HEK293 CELL LINE; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INTRACELLULAR SIGNALING; LUNG SLICE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY TRACT DISEASE; SMOOTH MUSCLE; ANTAGONISTS AND INHIBITORS; CELL CULTURE; DRUG EFFECTS; LUNG; METABOLISM; ORGAN CULTURE TECHNIQUE; RESPIRATION DISORDERS;

CELLS, CULTURED; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HEK293 CELLS; HELA CELLS; HUMANS; LUNG; MUSCLE, SMOOTH; OLIGOPEPTIDES; ORGAN CULTURE TECHNIQUES; RESPIRATION DISORDERS;

EID: 84958214596     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.115.100339     Document Type: Article

References (43)

1. Al-Muhsen S, Johnson JR, and Hamid Q (2011) Remodeling in asthma. J Allergy Clin Immunol 128:451-462.
2. An SS, Fabry B, Trepat X, Wang N, and Fredberg JJ (2006) Do biophysical properties of the airway smooth muscle in culture predict airway hyperresponsiveness? Am J Respir Cell Mol Biol 35:55-64.
3. Bel EH (2013) Clinical practice. Mild asthma. N Engl J Med 369:549-557.
4. Bernard R, Thach L, Kamato D, Osman N, and Little PJ (2014) Assessing the role of Gaq/11 in cellular responses: an analysis of investigative tools. Clin Exp Pharmacol 4:164.
5. Billington CK, Kong KC, Bhattacharyya R, Wedegaertner PB, Panettieri RA, Jr, Chan TO, and Penn RB (2005) Cooperative regulation of p70S6 kinase by receptor tyrosine kinases and G protein-coupled receptors augments airway smooth muscle growth. Biochemistry 44:14595-14605.
6. Bokoch GM, Katada T, Northup JK, Ui M, and Gilman AG (1984) Purification and properties of the inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase. J Biol Chem 259:3560-3567.
7. Borchers MT, Biechele T, Justice JP, Ansay T, Cormier S, Mancino V, Wilkie TM, Simon MI, Lee NA, and Lee JJ (2003) Methacholine-induced airway hyperresponsiveness is dependent on Galphaq signaling. Am J Physiol Lung Cell Mol Physiol 285:L114-L120.
8. Canning BJ and Fischer A (2001) Neural regulation of airway smooth muscle tone. Respir Physiol 125:113-127.
9. Carr R, Du Y, Quoyer J, Panettieri RA, Jr, Janz JM, Bouvier M, Kobilka BK, and Benovic JL (2014) Development and characterization of pepducins as Gs-biased allosteric agonists. J Biol Chem 289:35668-35684.
10. Chan P, Gabay M, Wright FA, Kan W, Oner SS, Lanier SM, Smrcka AV, Blumer JB, and Tall GG (2011a) Purification of heterotrimeric G protein alpha subunits by GST-Ric-8 association: primary characterization of purified G alpha(olf). J Biol Chem 286:2625-2635.
11. Chan P, Gabay M, Wright FA, and Tall GG (2011b) Ric-8B is a GTP-dependent G protein alphas guanine nucleotide exchange factor. J Biol Chem 286: 19932-19942.
12. Cisowski J, O'Callaghan K, Kuliopulos A, Yang J, Nguyen N, Deng Q, Yang E, Fogel M, Tressel S, and Foley C et al. (2011) Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer. Am J Pathol 179:513-523.
13. Cooper PR and Panettieri RA, Jr (2008) Steroids completely reverse albuterolinduced beta(2)-adrenergic receptor tolerance in human small airways. J Allergy Clin Immunol 122:734-740.
14. Cooper PR, Zhang J, Damera G, Hoshi T, Zopf DA, and Panettieri RA, Jr (2011) C-027 inhibits IgE-mediated passive sensitization bronchoconstriction and acts as a histamine and serotonin antagonist in human airways. Allergy Asthma Proc 32:359-365.
15. Covic L, Misra M, Badar J, Singh C, and Kuliopulos A (2002) Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation. Nat Med 8:1161-1165.
16. Deshpande DA and Penn RB (2006) Targeting G protein-coupled receptor signaling in asthma. Cell Signal 18:2105-2120.
17. Deshpande DA, Wang WC, McIlmoyle EL, Robinett KS, Schillinger RM, An SS, Sham JS, and Liggett SB (2010) Bitter taste receptors on airway smooth muscle bronchodilate by localized calcium signaling and reverse obstruction. Nat Med 16: 1299-1304.
18. Ediger TL and Toews ML (2000) Synergistic stimulation of airway smooth muscle cell mitogenesis. J Pharmacol Exp Ther 294:1076-1082.
19. Fabry B, Maksym GN, Butler JP, Glogauer M, Navajas D, and Fredberg JJ (2001) Scaling the microrheology of living cells. Phys Rev Lett 87:148102.
20. Fujii T and Kawashima K (2000) Ca21 oscillation and c-fos gene expression induced via muscarinic acetylcholine receptor in human T-and B-cell lines. Naunyn Schmiedebergs Arch Pharmacol 362:14-21.
21. Fujii T, Yamada S, Watanabe Y, Misawa H, Tajima S, Fujimoto K, Kasahara T, and Kawashima K (1998) Induction of choline acetyltransferase mRNA in human mononuclear leukocytes stimulated by phytohemagglutinin, a T-cell activator. J Neuroimmunol 82:101-107.
22. Fujioka M, Koda S, Morimoto Y, and Biemann K (1988) Structure of FR900359, a cyclic depsipeptide from Ardisia-Crenata Sims. J Org Chem 53:2820-2825.
23. Gilchrist A, Vanhauwe JF, Li A, Thomas TO, Voyno-Yasenetskaya T, and Hamm HE (2001) G alpha minigenes expressing C-terminal peptides serve as specific inhibitors of thrombin-mediated endothelial activation. J Biol Chem 276: 25672-25679.
24. Gosens R, Nelemans SA, Grootte Bromhaar MM, McKay S, Zaagsma J, and Meurs H (2003) Muscarinic M3-receptors mediate cholinergic synergism of mitogenesis in airway smooth muscle. Am J Respir Cell Mol Biol 28:257-262.
25. Hakonarson H and Grunstein MM (1998) Regulation of second messengers associated with airway smooth muscle contraction and relaxation. Am J Respir Crit Care Med 158:S115-S122.
26. Inamdar V, Patel A, Manne BK, Dangelmaier C, and Kunapuli SP (2015) Characterization of UBO-QIC as a Gaq inhibitor in platelets. Platelets 26:771-778.
27. Jamieson T, Clarke M, Steele CW, Samuel MS, Neumann J, Jung A, Huels D, Olson MF, Das S, and Nibbs RJ et al. (2012) Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis. J Clin Invest 122:3127-3144.
28. Karpinsky-Semper D, Volmar CH, Brothers SP, and Slepak VZ (2014) Differential effects of the Gb5-RGS7 complex on muscarinic M3 receptor-induced Ca21 influx and release. Mol Pharmacol 85:758-768.
29. Kong KC, Billington CK, Gandhi U, Panettieri RA, Jr, and Penn RB (2006) Cooperative mitogenic signaling by G protein-coupled receptors and growth factors is dependent on G(q/11). FASEB J 20:1558-1560.
30. Krymskaya VP, Orsini MJ, Eszterhas AJ, Brodbeck KC, Benovic JL, Panettieri RA, Jr, and Penn RB (2000) Mechanisms of proliferation synergy by receptor tyrosine kinase and G protein-coupled receptor activation in human airway smooth muscle. Am J Respir Cell Mol Biol 23:546-554.
31. Luo J, Busillo JM, and Benovic JL (2008) M3 muscarinic acetylcholine receptormediated signaling is regulated by distinct mechanisms. Mol Pharmacol 74: 338-347.
32. McLaughlin JN, Shen L, Holinstat M, Brooks JD, Dibenedetto E, and Hamm HE (2005) Functional selectivity of G protein signaling by agonist peptides and thrombin for the protease-activated receptor-1. J Biol Chem 280:25048-25059.
33. Moulton BC and Fryer AD (2011) Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPD. Br J Pharmacol 163:44-52.
34. Nishimura A, Kitano K, Takasaki J, Taniguchi M, Mizuno N, Tago K, Hakoshima T, and Itoh H (2010) Structural basis for the specific inhibition of heterotrimeric Gq protein by a small molecule. Proc Natl Acad Sci USA 107:13666-13671.
35. O'Callaghan K, Kuliopulos A, and Covic L (2012) Turning receptors on and off with intracellular pepducins: new insights into G-protein-coupled receptor drug development. J Biol Chem 287:12787-12796.
36. Panettieri RA, Murray RK, DePalo LR, Yadvish PA, and Kotlikoff MI (1989) A human airway smooth muscle cell line that retains physiological responsiveness. Am J Physiol 256:C329-C335.
37. Pelaia G, Renda T, Gallelli L, Vatrella A, Busceti MT, Agati S, Caputi M, Cazzola M, Maselli R, and Marsico SA (2008) Molecular mechanisms underlying airway smooth muscle contraction and proliferation: implications for asthma. Respir Med 102:1173-1181.
38. Scadding GW and Scadding GK (2010) Recent advances in antileukotriene therapy. Curr Opin Allergy Clin Immunol 10:370-376.
39. Stampfuss JJ, Schrör K, and Weber AA (2003) Inhibition of platelet thromboxane receptor function by a thrombin receptor-targeted pepducin. Nat Med 9: 1447.
40. Takasaki J, Saito T, Taniguchi M, Kawasaki T, Moritani Y, Hayashi K, and Kobori M (2004) A novel Galphaq/11-selective inhibitor. J Biol Chem 279: 47438-47445.
41. Taniguchi M, Nagai K, Arao N, Kawasaki T, Saito T, Moritani Y, Takasaki J, Hayashi K, Fujita S, and Suzuki K et al. (2003) YM-254890, a novel platelet aggregation inhibitor produced by Chromobacterium sp. QS3666. J Antibiot (Tokyo) 56:358-363.
42. Zaima K, Deguchi J, Matsuno Y, Kaneda T, Hirasawa Y, and Morita H (2013) Vasorelaxant effect of FR900359 from Ardisia crenata on rat aortic artery. J Nat Med 67:196-201.
43. Zhang P, Gruber A, Kasuda S, Kimmelstiel C, O'Callaghan K, Cox DH, Bohm A, Baleja JD, Covic L, and Kuliopulos A (2012) Suppression of arterial thrombosis without affecting hemostatic parameters with a cell-penetrating PAR1 pepducin. Circulation 126:83-91